603998 方盛製藥
按盤價 
11.450 -0.440 (-3.701%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 16.284 | 16.567 | 13.119 | 22.106 | 5.967 |
| 總資產報酬率 ROA (%) | 8.520 | 8.041 | 6.224 | 10.160 | 2.831 |
| 投入資產回報率 ROIC (%) | 11.246 | 10.655 | 8.286 | 14.412 | 4.057 | 邊際利潤分析 |
| 銷售毛利率 (%) | 71.275 | 71.850 | 68.098 | 67.283 | 64.054 |
| 營業利潤率 (%) | 23.923 | 16.053 | 12.063 | 18.529 | 6.362 |
| 息稅前利潤/營業總收入 (%) | 24.571 | 16.790 | 13.150 | 19.336 | 6.921 |
| 淨利潤/營業總收入 (%) | 21.172 | 14.056 | 11.030 | 15.441 | 4.462 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 77.271 | 85.916 | 75.810 | 44.270 | 119.633 |
| 價值變動淨收益/利潤總額(%) | 0.749 | 13.475 | -1.870 | 50.887 | -10.422 |
| 營業外收支淨額/利潤總額(%) | -0.223 | 0.225 | 3.390 | -1.673 | -9.806 | 償債能力分析 |
| 流動比率 (X) | 0.859 | 0.876 | 0.738 | 1.192 | 0.690 |
| 速動比率 (X) | 0.547 | 0.586 | 0.475 | 0.888 | 0.486 |
| 資產負債率 (%) | 42.201 | 46.890 | 48.434 | 48.401 | 51.797 |
| 帶息債務/全部投入資本 (%) | 23.758 | 30.134 | 33.877 | 30.423 | 27.052 |
| 股東權益/帶息債務 (%) | 302.811 | 220.094 | 183.662 | 210.940 | 245.510 |
| 股東權益/負債合計 (%) | 130.696 | 105.958 | 97.710 | 98.279 | 85.381 |
| 利息保障倍數 (X) | 35.040 | 23.958 | 19.796 | 17.386 | 6.143 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 56.893 | 46.570 | 42.791 | 42.267 | 48.957 |
| 存貨周轉天數 (天) | 275.403 | 253.410 | 218.853 | 171.968 | 149.076 |
| 備註： | 即時報價更新時間為 19/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
